Wave Life Sciences (WVE) Stock Price, Quote, News & History | Benzinga

Wave Life Sciences Inc (WVE) Stock Price, Quote, News & History

WVENASDAQ

Trade with Public

Trade with Public

$5.29

0.040.76%

At close: Aug 21, 5:00 PM EST

$5.33

0.03860.73%

After Hours: Aug 21, 5:00 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$5.30

Close

$5.29

Volume / Avg.

2.72M / 3.11M

Day Range

$5.27 - $5.48

52 Wk Range

5.01 - 21.73

Market Cap

$1.05B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

44

Short Interest

10.27%

Days to Cover

7.45

Recent Wave Life Sciences Ltd. News

Apple To Rally More Than 25%? Here Are 10 Top Analyst Forecasts For Tuesday

Top Wall Street analysts have changed their outlook on top names. For full analyst rating changes, including upgrades/downgrades, see analyst ratings page.

Avi Kapoor

Apellis Pharmaceuticals, Centessa Pharmaceuticals, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday

US stocks rise, Dow Jones gains 600+ pts. Apellis Pharma shares surge 136.4% after buyout by Biogen for $41/share. Other gainers incl. Centessa, Annexon, Agios, Fulcrum, Scholar Rock, Alkermes, Wave Life, Perimeter Solutions, Praxis Precision, and Century Aluminum.

Avi Kapoor

Crude Oil Gains 4%; Commercial Metals Posts Mixed Q2 Results

The U.S. trade deficit in goods shrank to $87.3 billion in February from $88.6 billion in January, while exports gained 8.7% to $142.0 billion. U.S. stocks traded lower, with the Nasdaq down 1%. Energy shares climbed 1.6%, while communication services fell 2.3%. CMC reported mixed results.

Avi Kapoor

Why Is Wave Life Sciences Stock Falling After Weight Loss Study Data?

Wave Life Sciences stock drops after INLIGHT Phase 1 data. WVE-007 shows fat reduction, lean mass stability, and biomarker suppression.

Vandana Singh

Wave Life Sciences Reclaims Rare Disease Drug From GSK, Targets Faster FDA Path

Wave Life Sciences regains full rights to WVE-006 from GSK, plans faster FDA talks as new trial data for a rare lung disease drug approach in 2026.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-191.58M

Investing Cash Flow (TTM)

-124.14M

Financing Cash Flow (TTM)

475.24M

Free Cash Flow (TTM)

-193.15M

Capital Expenditure (TTM)

-1.57M

Net Change in Cash (TTM)

159.53M

Analyst Trends and Forecast

6

Mar

3

Apr

3

May

3

Jul

1

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$595.37M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

15.10

PB Ratio (TTM)

2.28

Earnings Yield % (TTM)

-20.57%

Earnings Yield % (FWD)

-20.95%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$2.30

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$368.01M

Debt to Equity

0.10

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$5.30

Close

$5.29

Volume / Avg.

2.72M / 3.11M

Day Range

$5.27 - $5.48

52 Wk Range

5.01 - 21.73

Market Cap

$1.05B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

44

Short Interest

10.27%

Days to Cover

7.45

About

Sector

Health Care

Industry

Pharmaceuticals

WAVE Life Sciences Inc is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, com...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Wave Life Sciences (WVE) stock?

A

You can purchase shares of Wave Life Sciences (NASDAQ:WVE) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Wave Life Sciences (WVE) competitors?

A

Other companies in Wave Life Sciences’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).

Q

What is the forecast, or price target, for Wave Life Sciences (WVE) stock?

A

Wave Life Sciences has a consensus price target of $23.17.

Q

What is the current price for Wave Life Sciences (WVE)?

A

The stock price for Wave Life Sciences (NASDAQ: WVE) is $5.3286 last updated August 21, 2026 at 5:00 PM EDT.

Q

Does Wave Life Sciences (WVE) pay a dividend?

A

There are no upcoming dividends for Wave Life Sciences.

Q

When is Wave Life Sciences (NASDAQ:WVE) reporting earnings?

A

Wave Life Sciences does not have any upcoming earnings scheduled.

Q

Is Wave Life Sciences (WVE) going to split?

A

There is no upcoming split for Wave Life Sciences.

Q

What sector and industry does Wave Life Sciences (WVE) operate in?

A

Wave Life Sciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.